Breaking News Headlines Today | Ground News

Holiday Sale — Get 40% off Vantage for yourself or as a gift

journalgazette.net image

News from journalgazette.net

journalgazette.net’s aggregated media bias check is Center. This is a score we've assigned by combining the media bias ratings of a Center rating from Ad Fontes Media, a Center rating from Media Bias/Fact Check, a Center rating from from AllSides.

Is journalgazette.net credible or reliable? Our Factuality score answers both of those questions. When it comes to journalgazette.net, we’ve assigned a Very High factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about journalgazette.net

Where is journalgazette.net located?journalgazette.net's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

Center

byAd Fontes Media

Center

byMedia Bias/Fact Check

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top journalgazette.net News

Three 2-point conversions lead Seahawks' rally for OT win over Rams

Sam Darnold · Seattle

Three 2-point conversions lead Seahawks' rally for OT win over Rams

55% Center coverage: 38 sources

The Seattle Seahawks have rallied to stun the Los Angeles Rams and take a one-game lead in the NFC West.See the Story

China launches $113 billion free-trade experiment on Hainan island — REUTERS / ixx511

China Economy · Hainan

China launches $113 billion free-trade experiment on Hainan island

47% Left coverage: 17 sources

MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan

Technology · Japan

MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan

62% Center coverage: 16 sources

South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM® targeting the Japanese knee osteoarthritis market.See the Story

Blindspots

Cincinnati approves $8.1 million settlement with protesters arrested in 2020 — REUTERS / ixx511

Cincinnati approves $8.1 million settlement with protesters arrested in 2020 — REUTERS / ixx511

Cincinnati approves $8.1 million settlement with protesters arrested in 2020

Breaking News Topics Related to journalgazette.net